Gamma-glutamyl-transpeptidase to platelet ratio is not superior to APRI,FIB-4 and RPR for diagnosing liver fibrosis in CHB patients in China
Authors:
Open Access
- 17 August 2017
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-10
Abstract
The gamma-glutamyl transpeptidase to platelet ratio (GPR) is a novel index to estimate liver fibrosis in chronic hepatitis B (CHB). Few studies compared diagnostic accuracy of GPR with other non-invasive fibrosis tests based on blood parameters. We analyzed diagnostic values of GPR for detecting liver fibrosis and compared diagnostic performances of GPR with APRI (aspartate aminotransferase-to-platelet ratio index), FIB-4 (fibrosis index based on the four factors), NLR (neutrophil-to-lymphocyte ratio), AAR (aspartate aminotransferase/alanine aminotransferase ratio) and RPR (red cell distribution width-to-platelet ratio) in HBeAg positive CHB and HBeAg negative CHB. We found AUROCs of GPR in predicting significant liver fibrosis, advanced liver fibrosis and liver cirrhosis were 0.732 (95% CI 0.663 to 0.801), 0.788 (95% CI 0.729 to 0.847) and 0.753 (95% CI 0.692 to 0.814), respectively. Further comparisons showed the diagnostic performance of GPR was not significantly different with APRI, FIB-4 and RPR in identifying significant fibrosis, advanced fibrosis and cirrhosis, but it was significantly superior to AAR and NLR in both HBeAg positive CHB and HBeAg negative CHB. In conclusion, GPR does not show advantages than APRI, FIB-4 and RPR in identifying significant liver fibrosis, advanced liver fibrosis and liver cirrhosis in both HBeAg positive CHB and HBeAg negative CHB in China.Keywords
This publication has 32 references indexed in Scilit:
- RDW to Platelet Ratio: A Novel Noninvasive Index for Predicting Hepatic Fibrosis and Cirrhosis in Chronic Hepatitis BPLOS ONE, 2013
- Blood neutrophil-to-lymphocyte ratio independently predicts survival in patients with liver cirrhosisEuropean Journal of Gastroenterology & Hepatology, 2013
- Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver diseaseLiver International, 2011
- Liver stiffness measurement using FibroScan® is influenced by serum total bilirubin in acute hepatitisLiver International, 2009
- Hepatitis B virus infectionThe Lancet, 2009
- Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosisHepatology, 2008
- Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis BDigestive and Liver Disease, 2008
- Practices of Liver Biopsy in France: Results of a Prospective Nationwide SurveyHepatology, 2000
- An Algorithm for the Grading of Activity in Chronic Hepatitis CHepatology, 1996
- Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients With Chronic Hepatitis CHepatology, 1994